Prescription and Persistence of Antithrombotic Agents in Acute Ischemic Stroke or Transient Ischemic Attack Patients With MCA(Middle Cerebral Artery) Disease

Recruiting

Phase N/A Results N/A

Trial Description

Prescription and Persistence of Antithrombotic agents in Acute Ischemic Stroke or Transient Ischemic Attack Patients with MCA(Middle Cerebral Artery) Disease.

Conditions

Interventions

Trial Population

Prescription and Persistence of Antithrombotic Agents in Acute Ischemic Stroke or Transient Ischemic Attack Patients With MCA(Middle Cerebral Artery) Disease

Outcomes

Type Measure Time Frame Safety Issue
Primary Prescription status of Antithrombotic Agents at 12 months after baseline(onset)

Sponsors